This ADC product is comprised of an anti-CEACAM5 monoclonal antibody conjugated (clone hMN-14) via a linker to SN-38. The SN-38 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within
* VAT and and shipping costs not included. Errors and price changes excepted